

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | immunoglobulin mediated immune response (GO:0016064) | 3.69133067 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.37081634 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 3.37081634 |
| 4 | glyoxylate metabolic process (GO:0046487) | 3.33298152 |
| 5 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.29642390 |
| 6 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.29642390 |
| 7 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.26779665 |
| 8 | purine nucleotide salvage (GO:0032261) | 3.23662003 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 3.17496012 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.17496012 |
| 11 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.09183961 |
| 12 | complement activation, alternative pathway (GO:0006957) | 3.06025491 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 3.04803735 |
| 14 | glycolipid catabolic process (GO:0019377) | 3.03762933 |
| 15 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.02718954 |
| 16 | response to peptidoglycan (GO:0032494) | 2.94732158 |
| 17 | glycosphingolipid catabolic process (GO:0046479) | 2.93842197 |
| 18 | xenobiotic catabolic process (GO:0042178) | 2.93164123 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.92261447 |
| 20 | regulation of cholesterol esterification (GO:0010872) | 2.91914184 |
| 21 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.88782117 |
| 22 | epoxygenase P450 pathway (GO:0019373) | 2.87872410 |
| 23 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.84979327 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 2.81784066 |
| 25 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.81063188 |
| 26 | positive regulation of antigen processing and presentation (GO:0002579) | 2.79959987 |
| 27 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.77693044 |
| 28 | B cell mediated immunity (GO:0019724) | 2.76056158 |
| 29 | cellular response to arsenic-containing substance (GO:0071243) | 2.73517839 |
| 30 | aromatic amino acid family catabolic process (GO:0009074) | 2.72401623 |
| 31 | nucleotide salvage (GO:0043173) | 2.71553468 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 2.71490735 |
| 33 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.70031783 |
| 34 | ceramide catabolic process (GO:0046514) | 2.63788807 |
| 35 | regulation of antigen processing and presentation (GO:0002577) | 2.61207962 |
| 36 | urea metabolic process (GO:0019627) | 2.60630329 |
| 37 | urate metabolic process (GO:0046415) | 2.57910739 |
| 38 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.57208807 |
| 39 | NADH metabolic process (GO:0006734) | 2.56124513 |
| 40 | cellular response to zinc ion (GO:0071294) | 2.49017644 |
| 41 | angiotensin maturation (GO:0002003) | 2.48455080 |
| 42 | detection of bacterium (GO:0016045) | 2.48212018 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 2.47711710 |
| 44 | mature B cell differentiation involved in immune response (GO:0002313) | 2.47698808 |
| 45 | pinocytosis (GO:0006907) | 2.45093894 |
| 46 | urea cycle (GO:0000050) | 2.44945994 |
| 47 | regulation of fibrinolysis (GO:0051917) | 2.44719611 |
| 48 | NIK/NF-kappaB signaling (GO:0038061) | 2.44568210 |
| 49 | amino sugar catabolic process (GO:0046348) | 2.44445053 |
| 50 | negative regulation of fibrinolysis (GO:0051918) | 2.43133843 |
| 51 | membrane lipid catabolic process (GO:0046466) | 2.41208607 |
| 52 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.40688377 |
| 53 | response to interferon-beta (GO:0035456) | 2.40651468 |
| 54 | sulfur amino acid catabolic process (GO:0000098) | 2.40385523 |
| 55 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.38441888 |
| 56 | response to thyroid hormone (GO:0097066) | 2.37883797 |
| 57 | ethanol oxidation (GO:0006069) | 2.37527621 |
| 58 | tryptophan metabolic process (GO:0006568) | 2.37376773 |
| 59 | regulation of superoxide anion generation (GO:0032928) | 2.34329935 |
| 60 | detection of other organism (GO:0098543) | 2.33513536 |
| 61 | drug catabolic process (GO:0042737) | 2.32363662 |
| 62 | indole-containing compound catabolic process (GO:0042436) | 2.32317721 |
| 63 | indolalkylamine catabolic process (GO:0046218) | 2.32317721 |
| 64 | tryptophan catabolic process (GO:0006569) | 2.32317721 |
| 65 | sphingolipid catabolic process (GO:0030149) | 2.31825747 |
| 66 | acute-phase response (GO:0006953) | 2.31441621 |
| 67 | deoxyribonucleotide catabolic process (GO:0009264) | 2.31364032 |
| 68 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.29411669 |
| 69 | glycoside metabolic process (GO:0016137) | 2.29044718 |
| 70 | oligosaccharide catabolic process (GO:0009313) | 2.28728302 |
| 71 | positive regulation of B cell differentiation (GO:0045579) | 2.28189831 |
| 72 | exogenous drug catabolic process (GO:0042738) | 2.26529447 |
| 73 | negative regulation of granulocyte differentiation (GO:0030853) | 2.25266236 |
| 74 | oxaloacetate metabolic process (GO:0006107) | 2.24637814 |
| 75 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.24596214 |
| 76 | N-acetylneuraminate metabolic process (GO:0006054) | 2.24082209 |
| 77 | drug metabolic process (GO:0017144) | 2.23213960 |
| 78 | phospholipid efflux (GO:0033700) | 2.23213838 |
| 79 | branched-chain amino acid catabolic process (GO:0009083) | 2.23048874 |
| 80 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.22497480 |
| 81 | reactive oxygen species biosynthetic process (GO:1903409) | 2.20620832 |
| 82 | branched-chain amino acid metabolic process (GO:0009081) | 2.19812694 |
| 83 | fatty acid catabolic process (GO:0009062) | 2.19657096 |
| 84 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.19219511 |
| 85 | bile acid biosynthetic process (GO:0006699) | 2.18276660 |
| 86 | cellular metabolic compound salvage (GO:0043094) | 2.17784589 |
| 87 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.17752913 |
| 88 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.17258895 |
| 89 | regulation of protein activation cascade (GO:2000257) | 2.16972385 |
| 90 | fructose metabolic process (GO:0006000) | 2.16939767 |
| 91 | deoxyribose phosphate catabolic process (GO:0046386) | 2.16604043 |
| 92 | GDP-mannose metabolic process (GO:0019673) | 2.15019789 |
| 93 | purine-containing compound salvage (GO:0043101) | 2.15003665 |
| 94 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.13943342 |
| 95 | daunorubicin metabolic process (GO:0044597) | 2.13630721 |
| 96 | polyketide metabolic process (GO:0030638) | 2.13630721 |
| 97 | doxorubicin metabolic process (GO:0044598) | 2.13630721 |
| 98 | omega-hydroxylase P450 pathway (GO:0097267) | 2.13567022 |
| 99 | fibrinolysis (GO:0042730) | 2.12229138 |
| 100 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.12138159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.77228963 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.13314130 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.04179900 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.88994229 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.64173612 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.50168677 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.36156915 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.35682337 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.34468718 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.28957284 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.14506622 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.11221516 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.01830873 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99391107 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.98862329 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.97105058 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.95211607 |
| 18 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.94289265 |
| 19 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90876432 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.88873980 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.83522410 |
| 22 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.78268092 |
| 23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.77922152 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.76257628 |
| 25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.72924212 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.71376378 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.70807618 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68026159 |
| 29 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.67146259 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65641388 |
| 31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.65081261 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63658183 |
| 33 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.61854608 |
| 34 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.61465587 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57388164 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.52918077 |
| 37 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.52015481 |
| 38 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.50339807 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49445842 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49211146 |
| 41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.49157557 |
| 42 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.47824823 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47328378 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46310480 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42880234 |
| 46 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.40190225 |
| 47 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.39923741 |
| 48 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.38198241 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38035004 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37244758 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36600663 |
| 52 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36105350 |
| 53 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.35443354 |
| 54 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.33206615 |
| 55 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32589550 |
| 56 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.31941452 |
| 57 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.30163454 |
| 58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28816912 |
| 59 | MYC_22102868_ChIP-Seq_BL_Human | 1.28682779 |
| 60 | P68_20966046_ChIP-Seq_HELA_Human | 1.27950244 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.26959311 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26489615 |
| 63 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.25814437 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24574364 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23934819 |
| 66 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.23343789 |
| 67 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.22549217 |
| 68 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.21757143 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21744183 |
| 70 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.20211769 |
| 71 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19350487 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19197973 |
| 73 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18093873 |
| 74 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17431078 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17356203 |
| 76 | * MAF_26560356_Chip-Seq_TH2_Human | 1.14303173 |
| 77 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.12736116 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12521109 |
| 79 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11687596 |
| 80 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.11317653 |
| 81 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.11014503 |
| 82 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10162775 |
| 83 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09925081 |
| 84 | MYB_26560356_Chip-Seq_TH2_Human | 1.09150274 |
| 85 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08194224 |
| 86 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08172737 |
| 87 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06445942 |
| 88 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06155740 |
| 89 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05613139 |
| 90 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05354862 |
| 91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05307797 |
| 92 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.04922157 |
| 93 | P300_27268052_Chip-Seq_Bcells_Human | 1.04425450 |
| 94 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.03929802 |
| 95 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03219341 |
| 96 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.02846003 |
| 97 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.01791010 |
| 98 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00686397 |
| 99 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.99479275 |
| 100 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.99408237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.74054875 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.51155827 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.45593957 |
| 4 | MP0009840_abnormal_foam_cell | 3.44020860 |
| 5 | MP0005365_abnormal_bile_salt | 2.94756723 |
| 6 | MP0005360_urolithiasis | 2.90401369 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.67688979 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.58663236 |
| 9 | MP0009785_altered_susceptibility_to | 2.44487404 |
| 10 | MP0003436_decreased_susceptibility_to | 2.44211784 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.32606196 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.19933110 |
| 13 | MP0003195_calcinosis | 2.15601392 |
| 14 | MP0005025_abnormal_response_to | 2.11732501 |
| 15 | MP0003303_peritoneal_inflammation | 2.08023260 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.06885769 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.06648098 |
| 18 | MP0002419_abnormal_innate_immunity | 2.06217998 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 2.05724104 |
| 20 | MP0006082_CNS_inflammation | 2.00436909 |
| 21 | MP0001764_abnormal_homeostasis | 2.00039930 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 1.96560391 |
| 23 | MP0003724_increased_susceptibility_to | 1.91457440 |
| 24 | MP0005671_abnormal_response_to | 1.90309401 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.90236328 |
| 26 | MP0001790_abnormal_immune_system | 1.88556352 |
| 27 | MP0005387_immune_system_phenotype | 1.88556352 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.74060050 |
| 29 | MP0001800_abnormal_humoral_immune | 1.70589687 |
| 30 | MP0006036_abnormal_mitochondrial_physio | 1.70566195 |
| 31 | MP0009764_decreased_sensitivity_to | 1.68455533 |
| 32 | MP0003075_altered_response_to | 1.68234733 |
| 33 | MP0000685_abnormal_immune_system | 1.66632821 |
| 34 | MP0002723_abnormal_immune_serum | 1.66158670 |
| 35 | MP0001666_abnormal_nutrient_absorption | 1.66101800 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.65348914 |
| 37 | MP0008469_abnormal_protein_level | 1.63019468 |
| 38 | MP0003186_abnormal_redox_activity | 1.60263014 |
| 39 | MP0005451_abnormal_body_composition | 1.56487414 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.53268831 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.50903123 |
| 42 | MP0000604_amyloidosis | 1.50334679 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.48503161 |
| 44 | MP0001819_abnormal_immune_cell | 1.47009318 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.46552417 |
| 46 | MP0002132_abnormal_respiratory_system | 1.44243824 |
| 47 | MP0009278_abnormal_bone_marrow | 1.44010537 |
| 48 | MP0005332_abnormal_amino_acid | 1.42370483 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.38865971 |
| 50 | MP0000343_altered_response_to | 1.38518050 |
| 51 | MP0005319_abnormal_enzyme/_coenzyme | 1.32605771 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.29594896 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.29594896 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.29208383 |
| 55 | MP0010329_abnormal_lipoprotein_level | 1.25294602 |
| 56 | MP0009697_abnormal_copulation | 1.20688221 |
| 57 | MP0000716_abnormal_immune_system | 1.13936018 |
| 58 | MP0005166_decreased_susceptibility_to | 1.13297991 |
| 59 | MP0003252_abnormal_bile_duct | 1.13263796 |
| 60 | MP0001853_heart_inflammation | 1.12663348 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.12474469 |
| 62 | MP0000609_abnormal_liver_physiology | 1.11781065 |
| 63 | MP0002405_respiratory_system_inflammati | 1.11363465 |
| 64 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.08813117 |
| 65 | MP0002118_abnormal_lipid_homeostasis | 1.05044690 |
| 66 | MP0003763_abnormal_thymus_physiology | 1.04814271 |
| 67 | MP0000689_abnormal_spleen_morphology | 1.02966187 |
| 68 | MP0004019_abnormal_vitamin_homeostasis | 1.01818000 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.01518468 |
| 70 | MP0005636_abnormal_mineral_homeostasis | 0.98643546 |
| 71 | MP0003646_muscle_fatigue | 0.98425013 |
| 72 | MP0002398_abnormal_bone_marrow | 0.97846918 |
| 73 | MP0002429_abnormal_blood_cell | 0.97755575 |
| 74 | MP0005670_abnormal_white_adipose | 0.95921177 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 0.95342915 |
| 76 | MP0000858_altered_metastatic_potential | 0.94242710 |
| 77 | MP0004510_myositis | 0.93251486 |
| 78 | MP0003868_abnormal_feces_composition | 0.89997908 |
| 79 | MP0009763_increased_sensitivity_to | 0.88594386 |
| 80 | MP0005535_abnormal_body_temperature | 0.88118154 |
| 81 | MP0003300_gastrointestinal_ulcer | 0.87898889 |
| 82 | MP0004947_skin_inflammation | 0.85455613 |
| 83 | MP0002722_abnormal_immune_system | 0.84167519 |
| 84 | MP0005266_abnormal_metabolism | 0.82930022 |
| 85 | MP0005376_homeostasis/metabolism_phenot | 0.82789660 |
| 86 | MP0000490_abnormal_crypts_of | 0.82246531 |
| 87 | MP0005165_increased_susceptibility_to | 0.77969386 |
| 88 | MP0000465_gastrointestinal_hemorrhage | 0.77873982 |
| 89 | MP0005083_abnormal_biliary_tract | 0.77277957 |
| 90 | MP0008004_abnormal_stomach_pH | 0.75832818 |
| 91 | MP0000598_abnormal_liver_morphology | 0.74572564 |
| 92 | MP0009642_abnormal_blood_homeostasis | 0.74451502 |
| 93 | MP0001663_abnormal_digestive_system | 0.73921194 |
| 94 | MP0006035_abnormal_mitochondrial_morpho | 0.70345439 |
| 95 | MP0003866_abnormal_defecation | 0.69660527 |
| 96 | MP0001661_extended_life_span | 0.69583992 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.69387201 |
| 98 | MP0005310_abnormal_salivary_gland | 0.66944444 |
| 99 | MP0001873_stomach_inflammation | 0.66180953 |
| 100 | MP0001756_abnormal_urination | 0.65560504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 4.89546401 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.42694417 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.42694417 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.42694417 |
| 5 | Complement deficiency (HP:0004431) | 3.53329966 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.40120770 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.13585002 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 3.11101486 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 3.08563301 |
| 10 | Purpura (HP:0000979) | 3.06242902 |
| 11 | Dysostosis multiplex (HP:0000943) | 3.01037991 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.99169824 |
| 13 | Glomerulonephritis (HP:0000099) | 2.93535226 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.92117969 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.87740261 |
| 16 | Deep venous thrombosis (HP:0002625) | 2.86086882 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.85391363 |
| 18 | Abnormality of complement system (HP:0005339) | 2.80939344 |
| 19 | Increased muscle lipid content (HP:0009058) | 2.76507671 |
| 20 | Hyperammonemia (HP:0001987) | 2.76000392 |
| 21 | Petechiae (HP:0000967) | 2.74870651 |
| 22 | Abnormality of macrophages (HP:0004311) | 2.73901851 |
| 23 | Rhabdomyolysis (HP:0003201) | 2.73391683 |
| 24 | Dicarboxylic aciduria (HP:0003215) | 2.72920921 |
| 25 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.72920921 |
| 26 | Increased serum ferritin (HP:0003281) | 2.72688731 |
| 27 | Reduced antithrombin III activity (HP:0001976) | 2.71585318 |
| 28 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.67280476 |
| 29 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.67280476 |
| 30 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.67280476 |
| 31 | Recurrent bacterial skin infections (HP:0005406) | 2.66756455 |
| 32 | Increased intramyocellular lipid droplets (HP:0012240) | 2.65607148 |
| 33 | Prolonged neonatal jaundice (HP:0006579) | 2.63750715 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.61328830 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.59683647 |
| 36 | Obstructive lung disease (HP:0006536) | 2.59683647 |
| 37 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.59011916 |
| 38 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.59011916 |
| 39 | Loss of speech (HP:0002371) | 2.56326977 |
| 40 | Progressive neurologic deterioration (HP:0002344) | 2.54398395 |
| 41 | Generalized aminoaciduria (HP:0002909) | 2.52602584 |
| 42 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.52322785 |
| 43 | Myositis (HP:0100614) | 2.48152115 |
| 44 | Stomatitis (HP:0010280) | 2.47775966 |
| 45 | Prolonged partial thromboplastin time (HP:0003645) | 2.43407939 |
| 46 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.43127610 |
| 47 | Mucopolysacchariduria (HP:0008155) | 2.43127610 |
| 48 | Xanthomatosis (HP:0000991) | 2.40619505 |
| 49 | Eczematoid dermatitis (HP:0000976) | 2.38967482 |
| 50 | Mediastinal lymphadenopathy (HP:0100721) | 2.29779144 |
| 51 | Hepatic necrosis (HP:0002605) | 2.29194350 |
| 52 | Abnormality of iron homeostasis (HP:0011031) | 2.28800297 |
| 53 | Type I transferrin isoform profile (HP:0003642) | 2.27811525 |
| 54 | Ragged-red muscle fibers (HP:0003200) | 2.21698161 |
| 55 | Autoimmune thrombocytopenia (HP:0001973) | 2.21023903 |
| 56 | Hepatocellular necrosis (HP:0001404) | 2.18753095 |
| 57 | Meningitis (HP:0001287) | 2.18276662 |
| 58 | Joint hemorrhage (HP:0005261) | 2.18249747 |
| 59 | Mitochondrial inheritance (HP:0001427) | 2.15074329 |
| 60 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.13572415 |
| 61 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.12259928 |
| 62 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.10802180 |
| 63 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.10407663 |
| 64 | Amyloidosis (HP:0011034) | 2.08330531 |
| 65 | Hypobetalipoproteinemia (HP:0003563) | 2.07925765 |
| 66 | Ketosis (HP:0001946) | 2.07494153 |
| 67 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.04153374 |
| 68 | Cerebral palsy (HP:0100021) | 2.03813546 |
| 69 | Abnormal protein glycosylation (HP:0012346) | 1.99158229 |
| 70 | Abnormal glycosylation (HP:0012345) | 1.99158229 |
| 71 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.99158229 |
| 72 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.99158229 |
| 73 | Acute encephalopathy (HP:0006846) | 1.99023364 |
| 74 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.98992379 |
| 75 | Gingival bleeding (HP:0000225) | 1.98464179 |
| 76 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.97239681 |
| 77 | Hepatosplenomegaly (HP:0001433) | 1.97171070 |
| 78 | Lethargy (HP:0001254) | 1.96088687 |
| 79 | Lactic acidosis (HP:0003128) | 1.95903808 |
| 80 | Orchitis (HP:0100796) | 1.94484468 |
| 81 | Opisthotonus (HP:0002179) | 1.94044048 |
| 82 | 3-Methylglutaconic aciduria (HP:0003535) | 1.92220617 |
| 83 | Cerebral edema (HP:0002181) | 1.85649260 |
| 84 | Axonal loss (HP:0003447) | 1.85569056 |
| 85 | Increased CSF lactate (HP:0002490) | 1.85084552 |
| 86 | Myoglobinuria (HP:0002913) | 1.84440049 |
| 87 | Urticaria (HP:0001025) | 1.84062927 |
| 88 | Acute necrotizing encephalopathy (HP:0006965) | 1.83637458 |
| 89 | Nausea (HP:0002018) | 1.82976654 |
| 90 | Inflammation of the large intestine (HP:0002037) | 1.82726104 |
| 91 | Agammaglobulinemia (HP:0004432) | 1.80290011 |
| 92 | Gastrointestinal inflammation (HP:0004386) | 1.80142725 |
| 93 | Recurrent fungal infections (HP:0002841) | 1.79954530 |
| 94 | Abnormality of B cell number (HP:0010975) | 1.79572377 |
| 95 | Panhypogammaglobulinemia (HP:0003139) | 1.79537644 |
| 96 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.77832641 |
| 97 | Retinal atrophy (HP:0001105) | 1.77528073 |
| 98 | Sensorimotor neuropathy (HP:0007141) | 1.77332243 |
| 99 | Nephritis (HP:0000123) | 1.77245804 |
| 100 | Renal Fanconi syndrome (HP:0001994) | 1.76350338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.27645807 |
| 2 | BCKDK | 3.29767725 |
| 3 | ERN1 | 3.05630034 |
| 4 | MAP3K11 | 2.90496694 |
| 5 | TAOK3 | 2.80835849 |
| 6 | MAP4K2 | 2.68453991 |
| 7 | TESK2 | 2.49093944 |
| 8 | MAP4K1 | 2.42448605 |
| 9 | PIM2 | 2.35049096 |
| 10 | TBK1 | 2.26617785 |
| 11 | IRAK3 | 2.19979473 |
| 12 | TESK1 | 2.01747240 |
| 13 | VRK2 | 1.90763123 |
| 14 | MAP2K3 | 1.87377327 |
| 15 | SCYL2 | 1.79931500 |
| 16 | CSF1R | 1.79812116 |
| 17 | TYK2 | 1.75262975 |
| 18 | KDR | 1.73154940 |
| 19 | MAP3K14 | 1.63629171 |
| 20 | BLK | 1.62836724 |
| 21 | GRK6 | 1.56676250 |
| 22 | ABL2 | 1.54217088 |
| 23 | KIT | 1.47403332 |
| 24 | IKBKB | 1.46822527 |
| 25 | ARAF | 1.41503630 |
| 26 | TNK2 | 1.36589694 |
| 27 | BTK | 1.35343638 |
| 28 | SYK | 1.34966927 |
| 29 | JAK3 | 1.33163595 |
| 30 | IKBKE | 1.31323834 |
| 31 | STK16 | 1.31300370 |
| 32 | MAP3K3 | 1.30530529 |
| 33 | TAOK2 | 1.24565950 |
| 34 | GRK7 | 1.24005450 |
| 35 | RIPK4 | 1.22978987 |
| 36 | ZAP70 | 1.12869756 |
| 37 | FES | 1.08263600 |
| 38 | TXK | 1.07470857 |
| 39 | TGFBR2 | 1.01375495 |
| 40 | TAOK1 | 1.00914531 |
| 41 | TLK1 | 1.00141051 |
| 42 | LYN | 0.97292018 |
| 43 | LIMK1 | 0.96448188 |
| 44 | ITK | 0.96055979 |
| 45 | IRAK4 | 0.95523251 |
| 46 | MATK | 0.95254379 |
| 47 | ZAK | 0.87645912 |
| 48 | MAP2K6 | 0.87302493 |
| 49 | MAPKAPK3 | 0.86629062 |
| 50 | MAP2K2 | 0.84984830 |
| 51 | TEC | 0.84947691 |
| 52 | MAP3K5 | 0.82954888 |
| 53 | CSK | 0.82625728 |
| 54 | CDK19 | 0.78445688 |
| 55 | OBSCN | 0.77249755 |
| 56 | MAP3K1 | 0.73735470 |
| 57 | PINK1 | 0.71384331 |
| 58 | LCK | 0.69372863 |
| 59 | PRKCQ | 0.68740896 |
| 60 | VRK1 | 0.68570829 |
| 61 | LRRK2 | 0.68026219 |
| 62 | DAPK1 | 0.67079706 |
| 63 | MAP3K13 | 0.66374789 |
| 64 | RPS6KA5 | 0.65020479 |
| 65 | CAMKK2 | 0.60940175 |
| 66 | DYRK1B | 0.57240159 |
| 67 | DAPK3 | 0.54870338 |
| 68 | PDPK1 | 0.54844738 |
| 69 | HCK | 0.53925379 |
| 70 | PIM1 | 0.52758862 |
| 71 | ADRBK2 | 0.52679309 |
| 72 | PRKG2 | 0.51459938 |
| 73 | CCNB1 | 0.50410015 |
| 74 | PIK3CG | 0.48738532 |
| 75 | PDK2 | 0.47764118 |
| 76 | SIK1 | 0.44576951 |
| 77 | MAPK11 | 0.44353321 |
| 78 | PDK1 | 0.43339516 |
| 79 | MOS | 0.42796246 |
| 80 | PRKCD | 0.42449053 |
| 81 | TIE1 | 0.41604361 |
| 82 | FLT3 | 0.41311393 |
| 83 | MAP3K12 | 0.39631623 |
| 84 | MAP3K8 | 0.37026296 |
| 85 | MAPK7 | 0.36168232 |
| 86 | SIK3 | 0.35900412 |
| 87 | MAPK12 | 0.34586826 |
| 88 | FGR | 0.33872919 |
| 89 | IRAK2 | 0.33505941 |
| 90 | RPS6KC1 | 0.33373547 |
| 91 | RPS6KL1 | 0.33373547 |
| 92 | PBK | 0.31970213 |
| 93 | TRIB3 | 0.30484216 |
| 94 | GRK5 | 0.29972165 |
| 95 | MAPK4 | 0.29866264 |
| 96 | CSNK2A1 | 0.29295817 |
| 97 | DDR2 | 0.28531357 |
| 98 | MARK3 | 0.28457076 |
| 99 | CAMK2G | 0.27809385 |
| 100 | MAP3K10 | 0.27393968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.73788676 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.63114313 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.21006727 |
| 4 | Asthma_Homo sapiens_hsa05310 | 2.10507989 |
| 5 | Peroxisome_Homo sapiens_hsa04146 | 2.09939631 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.93734269 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 1.90244327 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.89758750 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.81850316 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 1.81040623 |
| 11 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.78914656 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.76685411 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.73902094 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.69462526 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69068066 |
| 16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.67969663 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.67614388 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.65530612 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.65114580 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.64713843 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64656092 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.63354668 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.59703401 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.57235338 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.55383802 |
| 26 | Sulfur relay system_Homo sapiens_hsa04122 | 1.52692938 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.49892699 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.46631581 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.41916545 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38590959 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.35232214 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.34404227 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.34240054 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.33495045 |
| 35 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.30195843 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.29817357 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.28516528 |
| 38 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.23924590 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.21083201 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.20455904 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19606371 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19125829 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.18381896 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13810799 |
| 45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13141752 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12215148 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.11978748 |
| 48 | Proteasome_Homo sapiens_hsa03050 | 1.11171269 |
| 49 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.10384960 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 1.07990240 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.07436780 |
| 52 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.06859126 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.03761610 |
| 54 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.03271317 |
| 55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.03241164 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00218226 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.98885317 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.98841028 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.98767191 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96205533 |
| 61 | Tuberculosis_Homo sapiens_hsa05152 | 0.96081421 |
| 62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94858791 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94493024 |
| 64 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.90264490 |
| 65 | Parkinsons disease_Homo sapiens_hsa05012 | 0.89623172 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88709571 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82070826 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81414891 |
| 69 | Ribosome_Homo sapiens_hsa03010 | 0.81358252 |
| 70 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.81239636 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76849976 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76606696 |
| 73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74130812 |
| 74 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74070152 |
| 75 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73816498 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.73727122 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71689592 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71026574 |
| 79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70920557 |
| 80 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70625123 |
| 81 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.69713364 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.68265951 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.68197883 |
| 84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.67993825 |
| 85 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.65469200 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64809047 |
| 87 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.62975822 |
| 88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62864236 |
| 89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62576943 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.61602883 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58672157 |
| 92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56551782 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.55261497 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55105449 |
| 95 | Base excision repair_Homo sapiens_hsa03410 | 0.54567593 |
| 96 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.53325751 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47608686 |
| 98 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47525532 |
| 99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47217148 |
| 100 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.47211089 |

